Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma-Reference-Cited by-同舟云学术

Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma

Published:1992-09 Issue:5 Volume:420 Page:433-440
ISSN:0174-7398
Container-title:Virchows Archiv A Pathological Anatomy and Histopathology
language:en
Short-container-title:Vichows Archiv A Pathol Anat

Author:

Schimmelpenning Hendrik,Eriksson Elina T.,Falkmer Ursula G.,Azavedo Edward,Svane Gunilla,Auer Gert U.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01600515.pdf

Reference50 articles.

1. Ali IU, Campbell G, Lidereau R, Callahan R (1988) Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma. Oncogene Res 3:139–146

2. Auer GU, Caspersson TO, Wallgren AS (1980) DNA content and survival in mammary carcinoma. Anal Quant Cytol 2:161–165

3. Auer G, Eriksson E, Azavedo E, Caspersson T, Wallgren A (1984a) Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res 44:394–396

4. Auer G, Fallenius A, Erhardt K, Sundelin B (1984b) Progression of mammary adenocarcinomas as reflected by nuclear DNA content. Cytometry 5:420–425

5. Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW (1990) Her-2/neu oncogene expression and proliferation in breast cancers. Am J Pathol 137:103–111

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profile of atypical hyperplasia of the breast;Breast Cancer Research and Treatment;2017-09-14

2. Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo;npj Breast Cancer;2017-05-01

3. Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer;Breast Cancer: Basic and Clinical Research;2016-01

4. Invasive cancers are not necessarily from preformed in situ tumours — an alternative way of carcinogenesis from misplaced stem cells;Journal of Cellular and Molecular Medicine;2013-06-07

5. Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer;World Journal of Surgical Oncology;2012-12